WESTLAKE Q4 FY25 earnings call WLK

Westlake undertook decisive actions in Q4 FY25 to restructure its businesses and reset its cost position, addressing persistent macroeconomic challenges^🌐. This included writing off $495 million in inventory and accruing expenses for the closure of 1 styrene, 3 chlorovinyl facilities in North America, and an epoxy facility in Pernis, Netherlands. Additionally, $16 million was accrued for HIP footprint optimization and a compounding business sale. These actions, totaling $511 million, are expected to contribute significantly to the company's 3-pillar strategy for earnings improvement in 2026.

The company outlined a 3-pillar strategy aimed at delivering $600 million in gross earnings improvement for 2026. The first pillar, footprint optimization, is expected to yield $200 million by closing higher-cost PEM assets and HIP fabrication sites. The second pillar focuses on improving plant reliability, targeting a $200 million year-over-year EBITDA improvement. The third pillar involves an additional structural company-wide cost reduction program, building on FY25's success, to deliver another $200 million in 2026. These initiatives are designed to create a more competitive and efficient operating model.

The Housing and Infrastructure Products (HIP) segment demonstrated stability in Q4 FY25 despite a seasonal decline in sales volume and lower new housing construction activity in North America, resulting in an 8% YoY sales decline. The segment's full-year 2025 EBITDA of $839 million and 20% margin were in line with expectations, supported by strong municipal pipe sales volumes due to infrastructure spending. HIP's broad geographical footprint and product offerings, including innovative PVCO pipe, helped it manage the slower residential construction environment better than the overall industry.

The Performance and Essential Materials (PEM) segment continued to face significant challenges in Q4 FY25, with a 5% sequential decline in average sales prices and a 2% lower sales volume. Global overcapacity, particularly in polyethylene and chlorovinyls, led to margin compression and a Q4 EBITDA of $45 million, down $45 million QoQ. In response, Westlake made the strategic decision to close non-integrated and higher-cost North American chlorovinyl assets, expecting an annual EBITDA benefit of $100 million starting in 2026 by reducing exposure to low-priced export markets.

Management expressed cautious optimism for 2026, citing signs of improvement in global industrial and manufacturing activity. The January U.S. ISM reading of 53 marked the first month in expansionary territory in a year, and the average 30-year mortgage rate dropped to 6.2%, improving housing affordability. These factors suggest potential sales volume growth in both segments for 2026, with a forecast of 1.3 million to 1.4 million housing starts. The company also noted early signs of restocking and price traction in PVC and caustic soda markets.

Westlake maintains a strong financial position with $2.9 billion in cash and securities and total debt of $5.6 billion as of December 31, 2025, with a 16-year average debt maturity life. The company returned $335 million to shareholders in FY25 through dividends and share repurchases. For 2026, capital expenditures are projected to be $900 million, a $100 million reduction year-over-year. The focus remains on strategic deployment of capital to create long-term shareholder value, with near-term opportunities predominantly in the HIP segment.